Three Months Ended
September 30, |
Nine Months Ended
September 30, | ||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||
Numerator: | |||||||||||||||||
Non-GAAP net income | $ | 21,214 | $ | 12,682 | $ | 72,220 | $ | 57,679 | |||||||||
Interest expense related to convertible notes, net of tax (1) | — | — | — | — | |||||||||||||
Numerator for non-GAAP diluted income per share | $ | 21,214 | $ | 12,682 | $ | 72,220 | $ | 57,679 | |||||||||
Denominator: | |||||||||||||||||
Weighted average shares outstanding, basic | 84,835 | 80,431 | 83,680 | 80,204 | |||||||||||||
Effect of dilutive shares | 3,590 | 4,916 | 4,174 | 4,653 | |||||||||||||
Non-GAAP diluted shares outstanding | 88,425 | 85,347 | 87,854 | 84,857 | |||||||||||||
Non-GAAP net income per share, diluted | $ | 0.24 | $ | 0.15 | $ | 0.82 | $ | 0.68 | |||||||||
(1) | Interest expense related to the convertible notes has been excluded from the numerator for non-GAAP diluted earnings per share because its effect would have been anti-dilutive. | ||||||||||||||||